{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T08:44:52Z","timestamp":1788425092785,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2006,4,1]]},"DOI":"10.1038\/sj.gt.3302684","type":"journal-article","created":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T06:28:27Z","timestamp":1133418507000},"page":"587-593","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Administration-route and gender-independent long-term therapeutic correction of phenylketonuria (PKU) in a mouse model by recombinant adeno-associated virus 8 pseudotyped vector-mediated gene transfer"],"prefix":"10.1038","volume":"13","author":[{"given":"Z","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Georgiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Th\u00f6ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,12,1]]},"reference":[{"key":"BF3302684_CR1","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/humu.10200","volume":"21","author":"CR Scriver","year":"2003","unstructured":"Scriver CR, Hurtubise M, Konecki D, Phommarinh M, Prevost L, Erlandsen H et al. PAHdb 2003: what a locus-specific knowledgebase can do. Hum Mutat 2003; 21: 333\u2013344.","journal-title":"Hum Mutat"},{"key":"BF3302684_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev.ge.28.120194.001041","volume":"28","author":"CR Scriver","year":"1994","unstructured":"Scriver CR, Eisensmith RC, Woo SL, Kaufman S . The hyperphenylalaninemias of man and mouse. Annu Rev Genet 1994; 28: 141\u2013165.","journal-title":"Annu Rev Genet"},{"key":"BF3302684_CR3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1542\/peds.108.4.972","volume":"108","author":"RR Howell","year":"2001","unstructured":"Howell RR, Chakravarti A, Dawson G, Dungy CI, Fletcher JM, Jackson D et al. National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16\u201318, 2000. Pediatrics 2001; 108: 972\u2013982.","journal-title":"Pediatrics"},{"key":"BF3302684_CR4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1542\/peds.112.S4.1514","volume":"112","author":"D Alexander","year":"2003","unstructured":"Alexander D . The National Institute of Child Health and Human Development and phenylketonuria. Pediatrics 2003; 112: 1514\u20131515.","journal-title":"Pediatrics"},{"key":"BF3302684_CR5","first-page":"165","volume":"15","author":"J Merrick","year":"2003","unstructured":"Merrick J, Aspler S, Schwarz G . Phenylalanine-restricted diet should be life long. A case report on long-term follow-up of an adolescent with untreated phenylketonuria. Int J Adolesc Med Health 2003; 15: 165\u2013168.","journal-title":"Int J Adolesc Med Health"},{"key":"BF3302684_CR6","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1038\/sj.gt.3301363","volume":"7","author":"CO Harding","year":"2000","unstructured":"Harding CO . \u2018Mommy, why can't I have a hamburger like the other kids?\u2019. Gene Therapy 2000; 7: 1969\u20131970.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1136\/bmj.2.6139.723","volume":"2","author":"I Smith","year":"1978","unstructured":"Smith I, Lobascher ME, Stevenson JE, Wolff OH, Schmidt H, Grubel-Kaiser S et al. Effect of stopping low-phenylalanine diet on intellectual progress of children with phenylketonuria. Br Med J 1978; 2: 723\u2013726.","journal-title":"Br Med J"},{"key":"BF3302684_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1023\/A:1020158631102","volume":"25","author":"R Koch","year":"2002","unstructured":"Koch R, Burton B, Hoganson G, Peterson R, Rhead W, Rouse B et al. Phenylketonuria in adulthood: a collaborative study. J Inherit Metab Dis 2002; 25: 333\u2013346.","journal-title":"J Inherit Metab Dis"},{"key":"BF3302684_CR9","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1542\/peds.112.S4.1530","volume":"112","author":"F Guttler","year":"2003","unstructured":"Guttler F, Azen C, Guldberg P, Romstad A, Hanley WB, Levy HL et al. Impact of the phenylalanine hydroxylase gene on maternal phenylketonuria outcome. Pediatrics 2003; 112: 1530\u20131533.","journal-title":"Pediatrics"},{"key":"BF3302684_CR10","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev.pharmtox.43.100901.140257","volume":"43","author":"NA Kootstra","year":"2003","unstructured":"Kootstra NA, Verma IM . Gene therapy with viral vectors. Annu Rev Pharmacol Toxicol 2003; 43: 413\u2013439.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BF3302684_CR11","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1182\/blood-2003-02-0495","volume":"102","author":"D Grimm","year":"2003","unstructured":"Grimm D, Zhou S, Nakai H, Thomas CE, Storm TA, Fuess S et al. Preclinical in vivo evaluation of pseudotyped adeno-associated virus vectors for liver gene therapy. Blood 2003; 102: 2412\u20132419.","journal-title":"Blood"},{"key":"BF3302684_CR12","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1182\/blood-2003-08-2954","volume":"103","author":"R Sarkar","year":"2004","unstructured":"Sarkar R, Tetreault R, Gao G, Wang L, Bell P, Chandler R et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 2004; 103: 1253\u20131260.","journal-title":"Blood"},{"key":"BF3302684_CR13","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1182\/blood-2004-07-2908","volume":"105","author":"VR Arruda","year":"2005","unstructured":"Arruda VR, Stedman HH, Nichols TC, Haskins ME, Nicholson M, Herzog RW et al. Regional intravascular delivery of AAV-2-F. IX to skeletal muscle achieves long-term correction of hemophilia B in a large animal model. Blood 2005; 105: 3458\u20133464.","journal-title":"Blood"},{"key":"BF3302684_CR14","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/nm1085","volume":"10","author":"P Gregorevic","year":"2004","unstructured":"Gregorevic P, Blankinship MJ, Allen JM, Crawford RW, Meuse L, Miller DG et al. Systemic delivery of genes to striated muscles using adeno-associated viral vectors. Nat Med 2004; 10: 828\u2013834.","journal-title":"Nat Med"},{"key":"BF3302684_CR15","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jgm.686","volume":"7","author":"JP Louboutin","year":"2005","unstructured":"Louboutin JP, Wang L, Wilson JM . Gene transfer into skeletal muscle using novel AAV serotypes. J Gene Med 2005; 7: 442\u2013451.","journal-title":"J Gene Med"},{"key":"BF3302684_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1073\/pnas.97.1.442","volume":"97","author":"M Glatzel","year":"2000","unstructured":"Glatzel M, Flechsig E, Navarro B, Klein MA, Paterna JC, Bueler H et al. Adenoviral and adeno-associated viral transfer of genes to the peripheral nervous system. Proc Natl Acad Sci USA 2000; 97: 442\u2013447.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302684_CR17","doi-asserted-by":"publisher","first-page":"6808","DOI":"10.1128\/JVI.78.13.6808-6817.2004","volume":"78","author":"JC Paterna","year":"2004","unstructured":"Paterna JC, Feldon J, Bueler H . Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J Virol 2004; 78: 6808\u20136817.","journal-title":"J Virol"},{"key":"BF3302684_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/73464","volume":"24","author":"MA Kay","year":"2000","unstructured":"Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A et al. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257\u2013261.","journal-title":"Nat Genet"},{"key":"BF3302684_CR19","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1182\/blood-2002-10-3296","volume":"101","author":"CS Manno","year":"2003","unstructured":"Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR et al. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963\u20132972.","journal-title":"Blood"},{"key":"BF3302684_CR20","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1089\/104303402760128577","volume":"13","author":"JA Wagner","year":"2002","unstructured":"Wagner JA, Nepomuceno IB, Messner AH, Moran ML, Batson EP, Dimiceli S et al. A phase II, double-blind, randomized, placebo-controlled clinical trial of tgAAVCF using maxillary sinus delivery in patients with cystic fibrosis with antrostomies. Hum Gene Ther 2002; 13: 1349\u20131359.","journal-title":"Hum Gene Ther"},{"key":"BF3302684_CR21","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1089\/104303403322124792","volume":"14","author":"TR Flotte","year":"2003","unstructured":"Flotte TR, Zeitlin PL, Reynolds TC, Heald AE, Pedersen P, Beck S et al. Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: a two-part clinical study. Hum Gene Ther 2003; 14: 1079\u20131088.","journal-title":"Hum Gene Ther"},{"key":"BF3302684_CR22","doi-asserted-by":"publisher","first-page":"11854","DOI":"10.1073\/pnas.182412299","volume":"99","author":"GP Gao","year":"2002","unstructured":"Gao GP, Alvira MR, Wang L, Calcedo R, Johnston J, Wilson JM . Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc Natl Acad Sci USA 2002; 99: 11854\u201311859.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302684_CR23","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/sj.gt.3300994","volume":"6","author":"N Chirmule","year":"1999","unstructured":"Chirmule N, Propert K, Magosin S, Qian Y, Qian R, Wilson J . Immune responses to adenovirus and adeno-associated virus in humans. Gene Therapy 1999; 6: 1574\u20131583.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR24","doi-asserted-by":"publisher","first-page":"11343","DOI":"10.1128\/JVI.76.22.11343-11349.2002","volume":"76","author":"H Nakai","year":"2002","unstructured":"Nakai H, Thomas CE, Storm TA, Fuess S, Powell S, Wright JF . A limited number of transducible hepatocytes restricts a wide-range linear vector dose response in recombinant adeno-associated virus-mediated liver transduction. J Virol 2002; 76: 11343\u201311349.","journal-title":"J Virol"},{"key":"BF3302684_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","volume":"79","author":"H Nakai","year":"2005","unstructured":"Nakai H, Fuess S, Storm TA, Muramatsu S, Nara Y, Kay MA . Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice. J Virol 2005; 79: 214\u2013224.","journal-title":"J Virol"},{"key":"BF3302684_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ymgme.2003.09.010","volume":"81","author":"Z Ding","year":"2004","unstructured":"Ding Z, Harding CO, Th\u00f6ny B . State-of-the-art 2003 on PKU gene therapy. Mol Genet Metab 2004; 81: 3\u20138.","journal-title":"Mol Genet Metab"},{"key":"BF3302684_CR27","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/sj.gt.3302262","volume":"11","author":"S Mochizuki","year":"2004","unstructured":"Mochizuki S, Mizukami H, Ogura T, Kure S, Ichinohe A, Kojima K et al. Long-term correction of hyperphenylalaninemia by AAV-mediated gene transfer leads to behavioral recovery in phenylketonuria mice. Gene Therapy 2004; 11: 1081\u20131086.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR28","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1203\/01.PDR.0000132837.29067.0E","volume":"56","author":"HJ Oh","year":"2004","unstructured":"Oh HJ, Park ES, Kang S, Jo I, Jung SC . Long-term enzymatic and phenotypic correction in the phenylketonuria mouse model by adeno-associated virus vector-mediated gene transfer. Pediatr Res 2004; 56: 278\u2013284.","journal-title":"Pediatr Res"},{"key":"BF3302684_CR29","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1073\/pnas.87.5.1965","volume":"87","author":"JD McDonald","year":"1990","unstructured":"McDonald JD, Bode VC, Dove WF, Shedlovsky A . Pahhph-5: a mouse mutant deficient in phenylalanine hydroxylase. Proc Natl Acad Sci USA 1990; 87: 1965\u20131967.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BF3302684_CR30","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1096-7192(02)00115-4","volume":"76","author":"JD McDonald","year":"2002","unstructured":"McDonald JD, Andriolo M, Cali F, Mirisola M, Puglisi-Allegra S, Romano V et al. The phenylketonuria mouse model: a meeting review. Mol Genet Metab 2002; 76: 256\u2013261.","journal-title":"Mol Genet Metab"},{"key":"BF3302684_CR31","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/j.febslet.2004.10.056","volume":"577","author":"B Th\u00f6ny","year":"2004","unstructured":"Th\u00f6ny B, Ding Z, Martinez A . Tetrahydrobiopterin protects phenylalanine hydroxylase activity in vivo: implications for tetrahydrobiopterin-responsive hyperphenylalaninemia. FEBS Lett 2004; 577: 507\u2013511.","journal-title":"FEBS Lett"},{"key":"BF3302684_CR32","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1016\/S0021-9258(18)61643-6","volume":"262","author":"FD Ledley","year":"1987","unstructured":"Ledley FD, Grenett HE, Woo SL . Biochemical characterization of recombinant human phenylalanine hydroxylase produced in Escherichia coli. J Biol Chem 1987; 262: 2228\u20132233.","journal-title":"J Biol Chem"},{"key":"BF3302684_CR33","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1038\/sj.gt.3301221","volume":"7","author":"JC Paterna","year":"2000","unstructured":"Paterna JC, Moccetti T, Mura A, Feldon J, Bueler H . Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Therapy 2000; 7: 1304\u20131311.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR34","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/geno.1996.4508","volume":"39","author":"JD McDonald","year":"1997","unstructured":"McDonald JD, Charlton CK . Characterization of mutations at the mouse phenylalanine hydroxylase locus. Genomics 1997; 39: 402\u2013405.","journal-title":"Genomics"},{"key":"BF3302684_CR35","first-page":"247","volume":"1","author":"B Fang","year":"1994","unstructured":"Fang B, Eisensmith RC, Li XH, Finegold MJ, Shedlovsky A, Dove W et al. Gene therapy for phenylketonuria: phenotypic correction in a genetically deficient mouse model by adenovirus-mediated hepatic gene transfer. Gene Therapy 1994; 1: 247\u2013254.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR36","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1203\/00006450-199904010-00003","volume":"45","author":"Y Nagasaki","year":"1999","unstructured":"Nagasaki Y, Matsubara Y, Takano H, Fujii K, Senoo M, Akanuma J et al. Reversal of hypopigmentation in phenylketonuria mice by adenovirus-mediated gene transfer. Pediatr Res 1999; 45: 465\u2013473.","journal-title":"Pediatr Res"},{"key":"BF3302684_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1089\/104303403764539387","volume":"14","author":"G Lizee","year":"2003","unstructured":"Lizee G, Aerts JL, Gonzales MI, Chinnasamy N, Morgan RA, Topalian SL . Real-time quantitative reverse transcriptase-polymerase chain reaction as a method for determining lentiviral vector titers and measuring transgene expression. Hum Gene Ther 2003; 14: 497\u2013507.","journal-title":"Hum Gene Ther"},{"key":"BF3302684_CR38","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ymthe.2005.03.020","volume":"12","author":"P Bell","year":"2005","unstructured":"Bell P, Wang L, Lebherz C, Flieder DB, Bove MS, Wu D et al. No evidence for tumorigenesis of AAV vectors in a large-scale study in mice. Mol Ther 2005; 12: 299\u2013306.","journal-title":"Mol Ther"},{"key":"BF3302684_CR39","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/sj.gt.3302417","volume":"12","author":"SM Kingsman","year":"2005","unstructured":"Kingsman SM, Mitrophanous K, Olsen JC . Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Therapy 2005; 12: 3\u20134.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR40","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1182\/blood-2002-09-2889","volume":"102","author":"AM Davidoff","year":"2003","unstructured":"Davidoff AM, Ng CY, Zhou J, Spence Y, Nathwani AC . Sex significantly influences transduction of murine liver by recombinant adeno-associated viral vectors through an androgen-dependent pathway. Blood 2003; 102: 480\u2013488.","journal-title":"Blood"},{"issue":"Suppl 1","key":"BF3302684_CR41","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.1038\/sj.gt.3302373","volume":"11","author":"TH Nguyen","year":"2004","unstructured":"Nguyen TH, Ferry N . Liver gene therapy: advances and hurdles. Gene Therapy 2004; 11 (Suppl 1): S76\u2013S84.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR42","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1517\/14712598.4.7.1073","volume":"4","author":"J Prieto","year":"2004","unstructured":"Prieto J, Qian C, Hernandez-Alcoceba R, Gonzalez-Aseguinolaza G, Mazzolini G, Sangro B et al. Gene therapy of liver diseases. Expert Opin Biol Ther 2004; 4: 1073\u20131091.","journal-title":"Expert Opin Biol Ther"},{"key":"BF3302684_CR43","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/sj.gt.3300653","volume":"5","author":"CO Harding","year":"1998","unstructured":"Harding CO, Wild K, Chang D, Messing A, Wolff JA . Metabolic engineering as therapy for inborn errors of metabolism \u2013 development of mice with phenylalanine hydroxylase expression in muscle. Gene Therapy 1998; 5: 677\u2013683.","journal-title":"Gene Therapy"},{"key":"BF3302684_CR44","doi-asserted-by":"crossref","unstructured":"Haberman RP, Kroner-Lux G, Samulski RJ . Production of adeno-associated viral vectors. Current Protocols in Human Genetics 1999, 12.9.1\u201312.9.17.","DOI":"10.1002\/0471142301.ns0417s09"},{"key":"BF3302684_CR45","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0076-6879(02)46069-7","volume":"346","author":"M Potter","year":"2002","unstructured":"Potter M, Chesnut K, Muzyczka N, Flotte T, Zolotukhin S . Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors. Methods Enzymol 2002; 346: 413\u2013430.","journal-title":"Methods Enzymol"},{"key":"BF3302684_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ymthe.2004.09.012","volume":"11","author":"NP van Til","year":"2005","unstructured":"van Til NP, Markusic DM, van der Rijt R, Kunne C, Hiralall JK, Vreeling H et al. Kupffer cells and not liver sinusoidal endothelial cells prevent lentiviral transduction of hepatocytes. Mol Ther 2005; 11: 26\u201334.","journal-title":"Mol Ther"},{"key":"BF3302684_CR47","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1089\/hum.2005.16.68","volume":"16","author":"KO Cresawn","year":"2005","unstructured":"Cresawn KO, Fraites TJ, Wasserfall C, Atkinson M, Lewis M, Porvasnik S et al. Impact of humoral immune response on distribution and efficacy of recombinant adeno-associated virus-derived acid alpha-glucosidase in a model of glycogen storage disease type II. Hum Gene Ther 2005; 16: 68\u201380.","journal-title":"Hum Gene Ther"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/3302684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302684","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/3302684.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T00:15:12Z","timestamp":1648599312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/3302684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,1]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2006,4,1]]}},"alternative-id":["BF3302684"],"URL":"https:\/\/doi.org\/10.1038\/sj.gt.3302684","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,1]]},"assertion":[{"value":"9 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2005","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2005","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2005","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}